Axa S.A. Vera Therapeutics, Inc. Transaction History

Axa S.A.

$33.1 Billion
Q2 2024

A detailed history of Axa S.A. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Axa S.A. holds 246,201 shares of VERA stock, worth $10.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

246,201

Previous 272,078 9.51%

Holding current value

$10.7 Million

Previous $11.7 Million 24.08%

% of portfolio

0.03%

Previous 0.04%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$33.72 - $48.82 $872,572 - $1.26 Million	-25,877 Reduced 9.51%	246,201 $8.91 Million
Q1 2024 May 15, 2024	SELL	$14.91 - $49.14 $1.65 Million - $5.44 Million	-110,613 Reduced 28.9%	272,078 $11.7 Million
Q4 2023 Jul 16, 2024	BUY	$9.29 - $16.0 $1.03 Million - $1.77 Million	110,613 Added 40.65%	382,691 $5.89 Million
Q4 2023 Feb 14, 2024	BUY	$9.29 - $16.0 $1.04 Million - $1.79 Million	111,698 Added 41.22%	382,691 $5.89 Million
Q3 2023 Nov 14, 2023	BUY	$13.71 - $19.64 $3.72 Million - $5.32 Million	270,993 New	270,993 $3.72 Million

Others Institutions Holding VERA

# of Institutions

182

Shares Held

54.7M

Call Options Held

42.2K

Put Options Held

121K

View Full List

About Vera Therapeutics, Inc.

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $1.17B
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

More about VERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account